This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Guelph directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Spatial and temporal patterns of porcine reproductive and respiratory syndrome virus (PRRSV) genotypes in Ontario, Canada, 2004-2007.
BMC veterinary research · 2014
Latest funding
- $148,989
Pandemic preparedness: Newcastle disease virus-vectored vaccine against HPAI H5
CIHR · 2024 · Co-investigator
- $150,000
Maintaining and Enhancing Flow Cytometry Capacity for Biological Research at the University of Guelph
NSERC · 2023 · Principal investigator
- $761,176
AAV-vectored immunoprophylaxis for the prevention and treatment of infectious diseases
CIHR · 2023 · Nominated PI
1 publications.
Spatial and temporal patterns of porcine reproductive and respiratory syndrome virus (PRRSV) genotypes in Ontario, Canada, 2004-2007.
Rosendal T, Dewey C, Friendship R, Wootton S, Young B, Poljak Z
Pandemic preparedness: Newcastle disease virus-vectored vaccine against HPAI H5
Principal investigators: Susta, Leonardo
Keywords: Avian Orthoavulavirus-1; Chickens; En Mass Vaccine Delivery; Lentogenic; Mucosal Immunity; Newcastle Disease Virus; Pandemic Preparedness Through Livestock Vaccination; Small Ruminants; Transmission Limitation; Waterfowl
Maintaining and Enhancing Flow Cytometry Capacity for Biological Research at the University of Guelph
Principal investigators: Wootton, Sarah
AAV-vectored immunoprophylaxis for the prevention and treatment of infectious diseases
Principal investigators: Wootton, Sarah
Keywords: Adeno-Associated Virus (Aav); Alternative Vaccine Platform; Anti-Drug Antibodies; Emerging Infectious Diseases; Immune Response To Aav; Immunoprophylaxis; Large Animal Models; Monoclonal Antibody; Recrudescence; Who Priority Pathogens
AAV-vectored immunoprophylaxis for the prevention and treatment of infectious diseases
Principal investigators: Wootton, Sarah
Keywords: Adeno-Associated Virus (Aav); Alternative Vaccine Platform; Anti-Drug Antibodies; Emerging Infectious Diseases; Immunoprophylaxis; Large Animal Models; Marburg; Monoclonal Antibody; Respiratory Syncytial Virus; Sars-Cov-2
High Throughput Real-Time PCR (qPCR) for AAC Genomics Core Lab
Principal investigators: VanDerKraak, Glen
Clinical advancement of a novel AAV lung gene therapy platform
Principal investigators: Wootton, Sarah
Development of an AAV gene therapy approach for the treatment of surfactant protein B deficiency
Principal investigators: Wootton, Sarah
Keywords: Acute Respiratory Distress; Adeno-Associated Virus; Alveolar Type Ii Cells; Gene Therapy; Monogenic Lung Disease; Surfactant Protein B Deficiency
CSV2020: The 3rd Symposium of the Canadian Society for Virology
Principal investigators: Wootton, Sarah
Keywords: Collaboration; Mentoring; Training; Virology Research; Virus
Vascular normalization improves immunotherapy in advanced stage ovarian cancer.
Principal investigators: Petrik, Jim J
Keywords: Advanced Stage Disease; Combination Therapy; Immunotherapy; Metronomic Chemotherapy; Ovarian Cancer; Pdx Models Of Ovarian Cancer; Translational Ovarian Cancer Research; Tumor Immunosuppression; Vascular Normalization
Clinical Advancement of an AAV Lung Gene Therapy Platform for the Treatment of Monogenic Lung Diseases
Principal investigators: Wootton, Sarah; Thompson, Brad; Thebaud, Bernard
Keywords: Abca3 Deficiency; Adeno-Associated Virus Vector; Alveolar Type Ii Cells; Cystic Fibrosis; Gene Editing; Gene Replacement; Monogenic Lung Diseases; Surfactant Protein B Deficiency; Surfactant Protein C; Toxic Gain Of Function
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.